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Background: Some reports describe lysis mechanisms by antimicrobial peptides (AMPs), while others describe
the activation of regulated cell death. In this study, we compare the cell death-inducing activities of four β-
hairpin AMPs (gomesin, protegrin, tachyplesin and polyphemusin II) along with their linear analogs in the
human erythroleukemia K562 cell line to investigate the relationship between their structure and activity.
Methods: K562 cells were exposed to AMPs. Morphological and biochemistry alterations were evaluated using
light microscopy, confocal microscopy and ﬂow cytometry.
Results: Gomesin and protegrin displayed cytotoxic properties that their linear counterparts did not. Tachy-
plesin and polyphemusin II and also their linear analogs induced cell death. We were able to distinguish
two ways in which these AMPs induced cell death. Lower concentrations of AMPs induced controlled cell
death mechanisms. Gomesin, tachyplesin and linear-tachyplesin promoted apoptosis that was characterized
by annexin labeling, sensitivity to Z-VAD, and caspase-3 activation, but was also inhibited by necrostatin-1.
Gomesin and protegrin induced cell death was dependent on intracellular Ca2+ mechanisms and the partic-
ipation of free radicals was observed in protegrin induced cell death. Polyphemusin II and its linear analog
mainly induced necrosis. Conversely, treatment with higher concentrations of AMPs primarily resulted in
cell membrane disruption, but with clearly different patterns of action for each AMP tested.
Conclusion: Different actions by β-hairpin AMPs were observed at low concentrations and at higher concen-
trations despite the structure similarity.
General signiﬁcance: Controlled intracellular mechanism and direct membrane disruption were clearly distin-
guished helping to understand the real action of AMPs in mammalian cells.© 2012 Elsevier B.V. Open access under the Elsevier OA license. 1. Introduction
The limited number of chemotherapeutic drugs available on the
market for use against cancer cells led to a frantic search for new
compounds. In recent years, several antimicrobial peptides (AMPs)
have been described as molecules with potential anti-cancer activity
[1–6]. AMPs are present in nearly all organisms displaying diverse tri-
dimensional structures. In general, AMPs are cationic, amphipathic
and with molecular weights of less than 10 kDa [7].
Studies performed in bacteria indicate that themain action of AMPs
involves the formation of membrane pores [8–11]. Conversely, studiesmica, Universidade Federal de
, SP, Brazil. Tel.: +55 11 5576
edes-Gamero),
vier OA license. in mammalian cells have shown that AMPsmay promote cell death by
apoptosis, autophagy or necrosis. For instance, magainin, a cationic
and amphipathic α-helix peptide, induces cell death by apoptosis in
HL-60 cells [12]. Tachyplesin, a peptide with a disulﬁde bridge that
forms a stabilized amphipathic β-hairpin structure [4], induces apo-
ptosis in HL-60 cells [13] but promotes membrane permeabilization
in a prostate carcinoma cell line [4]. Gomesin, another β-hairpin
AMP, presents high cytotoxic activity against cancer and normal cells
by regulatingmembrane permeabilization [1], although it also triggers
a complex intracellular Ca2+ signaling pathway prior to membrane
permeabilization [14]. In a hepatocellular carcinoma, peptaibols, a
family of antibiotic peptides from fungi, have been demonstrated to
suppress tumor growth by inducing Ca2+ inﬂux. This effect on Ca2+
inﬂux in turn leads to the activation of μ-calpain and promotion of
Bax translocation to themitochondria, triggering apoptosis and autop-
hagy, suggesting less evidence for amode of action viamembrane per-
meabilization [2]. There are few reports comparing how the structures
and activities of AMPs induce cell death in mammalian cells.
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sin, gomesin, polyphemusin II and protegrin) to induce cell death,
distinguishing whether cellular actions are different among them.
We also tested their corresponding linear (Lin) analogs and also
magainin II, a linear AMP. β-Hairpin AMPs such as tachyplesin and
polyphemusin II display antitumoral ability against leukemia cells
[13,15]. Therefore, in this study the human erythroleukemia K562
cell line was used as cellular model to investigate the effects of
these AMPs. Herein, we were able to distinguish diverse effects
among β-hairpin AMPs. We observed that at concentrations below
the EC50 AMPs promoted cell death by different intracellular mecha-
nisms depending on the AMP used, and at concentrations above the
EC50, AMPs induced diverse types of membrane disruptions.
2. Experimental procedures
2.1. Peptide synthesis
Peptides were synthesized manually by the solid-phase method
on a 4-methylbenzhydrylamine-resin (MBHAR) (0.8 mM/g) using
the t-Boc strategy [16]. Full deprotection and cleavage of the peptide
from the resin were carried out using anhydrous hydrogen ﬂuoride
(HF) treatment with anisole and dimethyl sulﬁde (DMS) as scaven-
gers at 0 °C for 1.5 h. Formation of disulﬁde bridges was achieved im-
mediately after the HF cleavage and extraction of the crude peptide.
The resulting peptide solution was kept at pH 6.8–7.0 and 5 °C for
72 h. Cyclization reactions were monitored by reverse-phase liquid
chromatography coupled to an electrospray ionization mass spec-
trometer (LC/ESI-MS). Lyophilized crude peptides were puriﬁed by
preparative RP-HPLC on a Vydac C18 column (25×250 mm, 300 Å
pore size, and 15 μm particle size) in two steps. The ﬁrst was per-
formed by using triethylammonium phosphate (TEAP) pH 2.25 as sol-
vent A and 60% acetonitrile (ACN) in A as solvent B. The second step
was carried out using 0.1% triﬂuoroacetic acid (TFA) H2O as solvent
A and 60% ACN in A as solvent B. Pure peptides were characterized
by amino acid analysis and by LC/ESI-MS. The sequences of the
AMPs are shown in Table 1.Table 1
Sequence and cytotoxicity activities of the peptides.
Peptides
Magainin G-I-G-K-F-L-H-S-A-K-K
Gomesin Z-C-R-R-L-C-
[Trp1,Ser2,6,11,15]-Gomesin or Lin-gomesin W-S-R-R-L-
Tachyplesin K-W-C-F-
[Trp0,Ser3,7,12,16]-Tachyplesin or Lin-tachyplesin W-K-W-S-F-
Polyphemusin II R-R-W-C-F-R
[Trp0,Ser4,8,13,17]-Polyphemusin II or polyphemusin II W-R-R-W-S-F-
Protegrin R-G-G-R-L-C
[Trp0,Ser6,8,13,15]-Protegrin or Lin-protegrin W-R-G-G-R-L-
a Cytotoxicity activities of the AMPs were evaluated against K562 erythroleukemia cell line.
b Z = pyroglutamic acid residue.2.2. Cell line and culture conditions
A K562 erythroleukemia cell line obtained from the American
Type Culture Collection (ATCC, USA), was cultured in suspension
in RPMI 1640 medium (Cultilab, Brazil) supplemented with 10%
fetal calf serum (FBS, Cultilab, Brazil), 100 U/ml of penicillin, and
100 μg/ml of streptomycin in a humidiﬁed atmosphere at 37 °C
in 5% CO2.
2.3. Cell viability assay
Cells were seeded in 96-well plates (105 cells/ml) and cultured
in medium containing 10% FBS in the presence or absence of AMPs
for 24 h. After this period, K562 cells were washed with PBS and
resuspended in binding buffer (0.01 M Hepes, pH 7.4, 0.14 M NaCl
and 2.5 mM CaCl2). The suspensions were labeled with annexin-
FITC and propidium iodide (PI) (Becton Dickinson, USA) according
to the manufacturer's instructions. The cells were incubated at
room temperature for 20 min. 10,000 events were collected per
sample. The analysis was performed in a FACSCalibur ﬂow cyt-
ometer (Becton Dickinson, USA) using the CellQuest software
(Becton Dickinson, USA).
2.4. Caspase-3 activity
K562 cells were treated with the AMPs as indicated, and activation
of caspase-3 was evaluated by ﬂow cytometry according to the man-
ufacturer's instructions (Cell Signaling, USA). After treatment, K562
cells were centrifuged, washed and ﬁxed in 2% paraformaldehyde in
PBS for 30 min. Cells were then permeabilized in PBS containing
0.01% saponin for 15 min and blocked in PBS containing 1% BSA for
30 min at room temperature. Afterwards, 10 μl of cleaved caspase-3
(Asp175) Alexa Fluor 488-conjugated antibody was added, and cells
were incubated in the dark at room temperature for 1 h. After wash-
ing, cells were resuspended in PBS and analyzed (10,000 events col-
lected per sample) in a FACSCalibur ﬂow cytometer (Becton
Dickinson, USA) using the CellQuest software.Sequences MW EC50
a
(µM)
-F-G-K-A-F-V-G-E-I-M-N-S-NH2 2465.95 >40 
Y-K-Q-R-C-V-T-Y-C-R-G-R-NH2
b 2270.72 4.5
S-Y-K-Q-R-S-V-T-Y-S-R-G-R-NH2 2285.62 >40 
R-V-C-Y-R-G-I-C-Y-R-R-C-R-NH2 2263.78 20
R-V-S-Y-R-G-I-S-Y-R-R-S-R-NH2 2389.76 21
-V-C-Y-K-G-F-C-Y-R-K-C-R-NH2 2425.97 22
R-V-S-Y-K-G-F-S-Y-R-K-S-R-NH2 2551.95 22
-Y-C-R-R-R-F-C-V-C-V-G-R-NH2 2155.64 12
S-Y-S-R-R-R-F-S-V-S-V-G-R-NH2 2281.64 >40 
1064 E.J. Paredes-Gamero et al. / Biochimica et Biophysica Acta 1820 (2012) 1062–10722.5. DNA content
Cells were treated with the indicated AMPs for 24 h. After this pe-
riod, cells were washed, ﬁxed and permeabilized as described previ-
ously. Then, cells were treated with 4 μg/ml RNase type I for 1 h at
37 °C and resuspended in PBS. Cells were stained with 5 μg/ml PI
and analyzed (12,000 events collected per sample) in a FACSCalibur
ﬂow cytometer using the CellQuest software. The DNA content was
evaluated using a FL2H detector on a logarithmic scale. The analysis
of the cell percentage in the sub-G0/G1 phase was performed using
the Winmdi 2.8 software.
2.6. ROS measurement
Levels of hydrogen peroxide were determined using 5-(and-
6)-chloromethyl-2′,7′-dichlorodihydroﬂuorescein diacetate (CM-
H2DCFDA; Invitrogen, USA). Treated cells were incubated with
10 μM CM-H2DCFDA for 30 min and washed with PBS. Fluorescent
signals were detected by ﬂow cytometry.
2.7. Ca2+ measurement
Intracellular Ca2+ was measured using confocal microscopy
equipped with a Plan-Apochromat 63× objective lens (NumericalFig. 1. Cytotoxicity curves of AMPs in K562 cells. K562 cells were treated with different con
annexin-V and PI staining following treatment with (A) magainin, (B) gomesin and Lin-gom
phemusin and Lin-polyphemusin. Results are the means±SEM of three independent experaperture 1.4) (Zeiss, LSM 780, Germany). K562 cells were incubated
with 4 μM Fluo-4/AM for 30 min at room temperature, and then
washed with Hank's Buffered Salt Solution (HBSS; composition in
mM: 137 NaCl, 5.4 KCl, 0.25 Na2HPO4, 0.44 KH2PO4, 1.3 CaCl2, 1.0
MgSO4, 4.2 NaHCO3). Fluo-4 was excited with an argon laser
(λEx=488 nm), and light emission was detected using a Zeiss META
detector (λEm=500–550 nm). The pinhole device was not used. Im-
ages were collected at approximately 5 s intervals. Fluorescence in-
tensity was normalized to basal ﬂuorescence levels using Examiner
3.2 (Zeiss, Germany) and Image J (USA) software [17,18].
2.8. Photomicrographic analysis
The Nikon Advanced Modulation Contrast method was used to
take photomicrographs. Photomicrographs of cultured cells were
obtained using a Nikon DS-Fi1 digital camera mounted on a
Nikon TS100 phase contrast microscope equipped with an Achro
LWD NAMC 40× objective lens (Numerical aperture 0.55) (Nikon
Instruments, USA).
2.9. Confocal microscopy
Nuclear evaluation was assessed by analysis of DNA binding to PI.
After treatment with AMPs, cells were ﬁxed and permeabilized ascentrations of AMPs for 24 h, and then evaluated. Cell viability was determined using
esin, (C) protegrin and Lin-protegrin, (D) tachyplesin and Lin-tachyplesin, and (E) poly-
iments performed in duplicate.
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PI for 15 min. After incubation, cells were placed onto glass coverslips
and mounted with Fluoromount-G.
The cellular membrane of K562 cells was labeled with 4 μg/ml
Alexa Fluor 488-conjugated wheat germ agglutinin (WGA) for
30 min and ﬁxed. Then, cells were placed onto glass coverslips and
mounted with Fluoromount-G.
Microscopy analyses were performed with a confocal laser scan-
ning microscope. The pinhole device was adjusted to capture ﬂuores-
cence of one airy unit in one focal section, and several Z stacks were
captured to analyze the total cellular volume. Images were obtained
using an argon laser (λEx=488 nm), and the emitted ﬂuorescence
was detected from 500 nm to 550 nm using a META detector (Zeiss,
Germany).
2.10. Statistical analysis
The Fluo-4 ﬂuorescence intensity was normalized to basal intensi-
ty (Ft/F0) and is shown as a representative pseudo-colored image
according to a ﬂuorescence intensity scale ranging from 0 (black) to
255 (white) [18]. All data represent at least three independent exper-
iments and were expressed as mean±standard error of the mean
(SEM). Statistical analyses were performed using Student's t-test for
comparison between two groups, and analysis of variance (ANOVA)
and Dunnett's post hoc test for multiple comparisons among groups.
A probability value of Pb0.05 was considered signiﬁcant.
3. Results
3.1. AMPs induce apoptosis, secondary necrosis, necrosis and necroptotic
cell death
To compare the cytotoxic abilities of AMPs against K562 erythro-
leukemia cell line, we employed annexin and PI assay. Annexin-V is
a protein that binds to phosphatidylserine that becomes exposed to
extracellular cell membrane during apoptosis, and PI is a nuclearFig. 2. The cytotoxic effects of AMPs occur via different modes of cell death. The type of cell d
staining. Results are presented as the percentage of viable (PI−An−), apoptotic (PI−An+), se
of three independent experiments performed in duplicate.stain that is impenetrant to viable cells [19]. Thus, annexin and PI
staining make it possible to differentiate between viable cells
(PI−An−), apoptotic cells (PI−An+), necrotic cells (PI+An−) and sec-
ondary necrosis of cells (PI+An+). Magainin II (an α-helical AMP),
four β-hairpin AMPs (gomesin, protegrin, tachyplesin and polyphe-
musin II), and their linear counterparts (Lin-gomesin, Lin-protegrin,
Lin-tachyplesin and Lin-polyphemusin II) were used in this study.
Linear analogs of β-hairpin AMPs were constructed by replacing Cys
by Ser at the position indicated in Table 1.
Magainin II displayed reduced cytotoxic activity in K562 cells up
to a concentration of 40 μM (Fig. 1A). Gomesin and protegrin were
the most potent cytotoxic AMPs in K562 cells, but their corresponding
linear analogs, Lin-gomesin and Lin-protegrin, lost their cytotoxic ac-
tivity (Fig. 1B and C). Tachyplesin and polyphemusin (Fig. 1D and E)
and notably, their linear analogs were cytotoxic for K562 cells
(Fig. 1D and E). A comparison of the cytotoxic activities of the AMPs
used in this study is shown in Table 1.
We observed differences in the mode of cell death depending on
the concentration of AMPs that correlated to their EC50 values. Gome-
sin, the most potent AMP, primarily induced apoptosis in K562 cells
(Fig. 2A), while tachyplesin and its linear counterpart promoted cell
death primarily by apoptosis and secondary necrosis (Fig. 2B). Prote-
grin, polyphemusin II and its linear analog mainly induced secondary
necrosis and necrosis (Fig. 2C and D).
To corroborate the effects described above, caspase inhibitor Z-
VAD was used. Cells were incubated with the inhibitor for 1 h before
the addition of AMPs. Z-VAD was able to reduce gomesin, tachyplesin
and Lin-tachyplesin induced cell death, whereas the cell death, which
involves a high percentage of secondary necrosis or necrosis, induced
by protegrin, polyphemusin II and Lin-polyphemusin II was not af-
fected (Fig. 3A). In addition, the activity of caspase-3 in the presence
of AMPs was evaluated. Caspase-3 is an effector caspase that plays an
important role in the execution phase of apoptosis [20]. Among the
peptides tested, gomesin and tachyplesin were able to produce the
cleaved active form of pro-caspase-3, conﬁrming that gomesin and
tachyplesin induce apoptosis in K562 cells (Fig. 3B).eath induced by AMPs was evaluated by ﬂow cytometry analysis using annexin-V and PI
condary apoptotic (PI+An+) and necrotic (PI+An−) cells. Results are the means±SEM
Fig. 3. Cell death induced by gomesin, tachyplesin and Lin-tachyplesin occurs by apoptosis. K562 cells were treated with each peptide at the cytotoxic EC50 for 24 h, and then eval-
uated. (A) Pretreatment of cells with 20 μM Z-VAD, a caspase inhibitor, decreased cell death induced by gomesin, tachyplesin and Lin-tachyplesin, whereas the effect of protegrin,
polyphemusin and Lin-polyphemusin treatment on cell death was not altered. Results are the means±SEM of three independent experiments performed in duplicate. *Pb0.05, T-
test. (B) Flow cytometric analysis of endogenous levels of activated caspase-3 in K562 cells. Filled and open histograms represent unstimulated and stimulated samples, respective-
ly. Data are representative of three experiments.
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treated with all AMPs at the EC50 concentration (Fig. 4A). Quantiﬁca-
tion of cells with low DNA content (sub-diploid cells or sub-G1/G0)
was performed by ﬂow cytometry. Sub-diploid cells signiﬁcantly but
modestly increased with the use of all AMPs (Fig. 4B). Quantiﬁcation
of DNA content in cells treated with higher concentrations of AMPs
was not possible because an extensive disruption of the cells was ob-
served (data not shown).
The elicitation of intracellular oxidative stress is a characteris-
tic of several cytotoxic agents [21–24]. Thus, free radicals were
quantiﬁed using the CM-H2DCFDA ﬂuorophore. Among the AMPs,
only protegrin led to a rise in free radicals after 24 h of treatment
at the cytotoxic EC50 concentration for that AMP (Fig. 4C). The
participation of free radicals in the cell death induced by prote-
grin was conﬁrmed by the use of N-Acetyl-Cysteine (NAC), a
thiol redox, which was able to inhibit cell death induced by pro-
tegrin (Fig. 4D). NAC could reduce the disulﬁde bridge in proteins[25], therefore the hypothesis of NAC to break the bridges of
protegrin was tested. Protegrin and gomesin were incubated at
different times with NAC, but no reduction of the peptide's
bridges was observed by LC–MS (data not shown). In addition,
NAC was not able to reduce the cytotoxic effect of gomesin (data
not shown).
In addition, a necroptosis inhibitor, necrostatin-1, and an intra-
cellular Ca2+ chelator, BAPTA-AM, were used. Necrostatin-1, a spe-
ciﬁc inhibitor of receptor-interacting protein 1 (RIP-1) kinase [26],
inhibited induced cell death by gomesin, tachyplesin and Lin-
polyphemusin II (Fig. 5A), while BAPTA-AM reduced the cell
death promoted by gomesin and protegrin (Fig. 5B). Moreover,
quantiﬁcation of intracellular Ca2+ was assessed by confocal mi-
croscopy. We observed that gomesin and protegrin were able to in-
duce an increase in Ca2+ levels in K562 cells, demonstrating that
the Ca2+ ion participates in cell death induced by gomesin and
protegrin (Fig. 5C).
Fig. 4. Characterization of cell death induced by AMPs. K562 cells were treated with the EC50 of each peptide for 24 h, and then evaluated. (A) AMP-induced nuclear morphological
features were visualized by confocal microscopy. Micrographs of control cells were stained with PI. Representative photomicrographs of two independent experiments are shown.
Bars=10 μm. (B) Measurement of cells with low DNA content performed by ﬂow cytometry. (C) AMP-induced ROS generation was detected using the CM-H2DCFDA ﬂuorophore.
(D) The cells were incubated for 1 h with NAC previously to stimulus. Then, 10 μM protegrin was added in the presence of NAC. Results are the means±SEM of three independent
experiments performed in duplicate. *Pb0.05, ANOVA test.
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The evaluation of cell death by ﬂow cytometry using higher con-
centrations of AMPs (above EC50 levels) revealed a second effect on
cells by AMPs: cell membrane permeabilization (Supplementary ma-
terial, Fig. S1). Representative contour plots showed the mode of cell
death induced by AMPs using the cytotoxic EC50 concentration for
each AMP or a concentration of 40 μM (Supplementary material, Fig.
S1). All the AMPs that displayed cytotoxic activity induced cell
death permeabilization at a concentration above the EC50. The perme-
abilization of cell membranes was evidenced by PI uptake. The images
in Fig. 6 allowed us to visualize details of membrane disruption upon
treatment with AMPs for 24 h. A total disruption of the cell mem-
brane was observed at high concentrations of gomesin. Treatment
with tachyplesin and Lin-tachyplesin also led to a substantial alter-
ation in the cell membrane, but some intact cells remained. Protegrin
treatment produced rounding and swelling of cells, which is typical in
necrotic cell death, and treatment with polyphemusin II and its linear
analog also disrupted the cell membranes of K562 cells. However,treatment with magainin II, Lin-gomesin and Lin-protegrin, which
possess low cytotoxic activity in K562 cells, did not promote visible
alterations in the cell membranes. Light forward scatter and light
side scatter, which correspond to size of cells and their granulation
respectively, were quantiﬁed after treatment with AMPs (Supple-
mentary material Fig. S2). All AMPs reduce the cell size after 24 h of
treatment and the most of them, except tachyplesin and Lin-
tachyplesin, promote increase of cell granulation likely by increase
of density (Supplementary material, Fig. S2).
In addition, we analyzed the effect of treatment with 40 μM of
AMPs on cell membranes using time-lapse capture in a light micro-
scope. The time-lapse images revealed important differences of cell
death induced by different AMPs. Gomesin induced some cellular
swelling until a permeabilization in a speciﬁc area resulted in the re-
lease of the intracellular contents, and in some cases, membrane bleb-
bing was observed (Supplementary material Fig. S3A). Protegrin
induced cell death was different from that induced by the other
AMPs. Protegrin induced an initial blebbing in all cells observed fol-
lowed by high amplitude swelling of the cells (Supplementary
Fig. 5. Necroptotic cell death induced by AMPs and altered intracellular Ca2+ levels. K562 cells were treated with the EC50 of each peptide for 24 h, and then evaluated. (A) Pre-
treatment of cells with 20 μM necrostain-1, a RIP-1 kinase inhibitor, decreased cell death induced by gomesin, tachyplesin and Lin-polyphemusin, whereas the effect of treatment
with protegrin, Lin-tachyplesin and polyphemusin on cell death was not altered. (B) Incubation of cells with 10 μM BAPTA-AM, an intracellular Ca2+ chelator, only decreased cell
death in gomesin and protegrin treated cells. (C) Confocal images are shown using pseudocolor image according to a ﬂuorescence intensity scale (0 = black, 255 = white). Rep-
resentative images of basal [Ca2+]i intensity and the intensity following protegrin and gomesin stimulation are shown. The records of ﬂuorescence intensity as a function of time
correspond to the images shown on the right. Each trace represents the temporal Fluo-4 ﬂuorescence intensity of one cell. (A–B) Results are the means±SEM of three independent
experiments performed in duplicate. *Pb0.05, T-test.
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brane blebbing followed by swelling, which ultimately resulted in
membrane disruption (Supplementary material Figs. S3C and S4A).
Tachyplesin took the longest time of the AMPs to induce membrane
disruption. Polyphemusin II promoted cell death started with small
membrane blebbings and high amplitude swelling of the cells (Sup-
plementary material Fig. S4B). Finally, Lin-polyphemusin II promotes
a blebbing that increase by all extension of cell until the disruption of
cell membrane (Fig. S4C). Using image software temporal alterations
in cell shape, volume and blebbing were analyzed. The sequence of
cell evaluation after stimulus with each peptide is shown in supple-
mentary material (see Movies in supplementary material and Figs.
S5–S10). Although AMPs induce rapid necrotic cell death with typical
membrane permeabilization, it was possible to observe a diverse
form of membrane alteration for each AMP. A common feature
among them was the volume increase after stimulation. Polyphemu-
sin II was the only AMP that did not promote blebbing formation
leading directly to intracellular condensation and membrane perme-
abilization (Supplementary material, Fig. S9). For the other AMPs
the blebbings appear in different numbers and a transient increase
was observed, but after some minutes, with swelling formation, the
blebbings are fused with the cell (Supplementary material, Fig. S5–
S10).Evaluation of cell membranes 24 h after treatment with AMPs at
the EC50 concentration was performed by confocal microscopy. The
cell membrane was labeled with WGA, a lectin that binds to N-
acetylglucosamine [27]. A focal plane from the middle of the cells is
shown in Fig. 7A. Control samples and cells stimulated with AMPs
with low cytotoxic effects, such as magainin II, Lin-gomesin and Lin-
protegrin, showed a homogeneous distribution of WGA labeling. In
addition, AMPs that were cytotoxic to K562 cells caused accumulation
of labeled WGA (Fig. 7A). Spatial evaluation of cells (control and
gomesin treated cells were rotated 90° degrees) revealed a decrease
in cell size after gomesin treatment, which explains the accumulation
of WGA labeling observed (Fig. 7B).
Conversely, treatment with high concentrations of gomesin
completely damaged the cell membrane (Fig. 7C). This explains the
ﬂow cytometry results in which all cells treated with gomesin stained
positive for annexin and PI (Supplementary material Fig. S11A–B). Fi-
nally, the direct effect on cell membrane of gomesin was isolated de-
creasing cellular metabolism and performing cell death evaluation
after 1 h. To decrease endocytosis of AMPs cell death curves were
constructed at 4 °C or in the presence of cytochalasin D. Both treat-
ments promote the shift of curve to right. The concentrations of
5–10 μM, which correspond to the range with apoptosis activity,
were the most affected in these conditions. However, the effect of
Fig. 6. Morphology of cells after treatment with AMPs. Photomicrographic observation of cell morphology was performed in cells treated with the cytotoxic EC50 or 40 μM of each
peptide for 24 h. For magainin, Lin-gomesin and Lin-protegrin, a concentration of 20 μM was used. Bar=25 μm.
1069E.J. Paredes-Gamero et al. / Biochimica et Biophysica Acta 1820 (2012) 1062–1072concentration of 40 μM gomesin was not affected indicating that at
this concentration the primarily effect occurs independent of cellular
mechanism and occurs by a direct action of cell permeabilization.
4. Discussion
Several reports have described the antitumor activity of cationic
AMPs; however, their speciﬁc mechanism of action in mammalian
cells and its relation with their spatial structure remain unclear. Stud-
ies involving the intracellular mechanism of AMPs have revealed sub-
stantial differences in the manner in which AMPs induce cell death
and in their preference to act on cancer or normal cells.
In this study, we investigated the capability of four β-hairpin
AMPs, gomesin, protegrin, tachyplesin and polyphemusin II, and
their corresponding linear analogs to induce cell death in K562
cells. Magainin II, an α-helix AMP, was also tested to compare
the effects with the ones caused by the linear analogs. It was pos-
sible to distinguish diverse effects among these β-hairpin AMPs
despite their structural similarities. We observed that the treat-
ment with low concentrations of AMPs induced cell death by acti-
vation of several intracellular mechanisms, while treatment with
high concentrations of AMPs induced rapid membrane disruption
with diverse characteristics.
4.1. Differences in cell death mechanisms by AMPs at low concentration
Among the peptides used, magainin II exhibited the lowest cyto-
toxicity in K562 cells at concentrations below 40 μM, similar to
what has been observed in other cell types [28–30]. Linear analogsof gomesin and protegrin also showed low cytotoxic activity
(Fig. 1). However, linear counterparts of tachyplesin and polyphemu-
sin did not exhibit a decrease in their cytotoxicity (Fig. 1). This sug-
gests that the substitution of Cys by Ser, which leads to the
assumption of α-helix secondary structures by peptides [31,32], is
not enough to reduce the cytotoxic properties of these molecules. In
general, Lin-tachyplesin and Lin-polyphemusin II acted similarly to
their native molecules, as observed when their potency and efﬁcacy
were compared (Fig. 1 and Table 1). However, differences were
found when the nature of cell death induced by tachyplesin, polyphe-
musin II and their corresponding counterparts were compared. Sec-
ondary necrosis, apoptosis and necrosis were induced to a similar
extent by tachyplesin, whereas Lin-tachyplesin treatment showed a
lower percentage of necrosis (Fig. 2). The cell death induced by
both AMPs was reduced by treatment with Z-VAD, a caspase inhibitor
(Fig. 3A). Another difference between Lin-tachyplesin and tachyple-
sin was that only tachyplesin was able to induce the cleavage of
caspase-3 (Fig. 3A). Polyphemusin II induced mainly necrotic cell
death, whereas its analog induced largely secondary necrosis (Fig. 2).
The differences observed in cellular responses to tachyplesin and
polyphemusin II treatment are important because a high degree of
homology exists between these AMPs (Table 1). Polyphemusin II
and tachyplesin have the same seven amino acids residues at their
C-termini strand. However, tachyplesin possesses two positive
amino acids, Lys1 and Arg9, whereas polyphemusin II possesses
three positive amino acids, Arg1, Arg2 and Lys10 (Table 1). In the
strand N-termini a high degree of homology is also observed. The dif-
ferences are the substitution of an Arg by a Lys and a Phe by an Ile
(Table 1). The similarity between these two molecules can explain
Fig. 7. Visual evaluation of cellular membranes after treatment with AMPs. Confocal images were captured in cells treated with the EC50 or 40 μM of each peptide for 24 h. A con-
centration of 20 μM was used for magainin, Lin-gomesin and Lin-protegrin. Bar=5 μm. (A) The images shown are representative images of one focal plane. High levels of ﬂuores-
cence (arrows) can be observed after incubation of cells with gomesin, protegrin, polyphemusin and Lin-polyphemusin. (B) Images in XY were acquired in a single confocal optical
image, and a 3D image was constructed and rotated 90°. Images of control samples and cells stimulated with gomesin are shown. (C) The disruption of the cell membrane can be
observed in cells treated with 40 μM of AMPs with cytotoxic ability.
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explain the difference observed in the mechanism by which cell death
is activated.
Gomesin and protegrin also have a partial homology. These
AMPs have four similar amino acids (Arg-Leu-Cys-Tyr) in their C-
termini, but gomesin has a larger amino acid chain in its N-
terminus (Table 1). The linear analogs for both of these moleculeslost their cytotoxic abilities. In addition, Ca2+ signaling participates
in both gomesin and protegrin cell death-induction (Fig. 5B and C).
Gomesin was the most potent AMP inducer of cell death of the
AMPs and promoted apoptosis characterized by phosphatidylserine
externalization and caspase-3 activation without cellular membrane
permeabilization (Figs. 1B, 2A and 3B). However, in cancer cell lin-
eages such as B16 melanoma [1], SH-SY5Y neuroblastoma and PC12
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Ca2+-dependent membrane permeabilization [14]. As observed for
gomesin and other AMPs, multiple cell death pathways were acti-
vated. Thus, apoptosis and necroptosis, both often dependent on
Ca2+ signaling, could be activated simultaneously in K562 cells,
explaining the inhibitory effect of Z-VAD and necrostatin-1
(Figs. 3A and 5A). This explanation could also extend to the inhibi-
tion of tachyplesin by necrostatin-1 (Fig. 5A). Conversely, necrosis
was the primary type of cell death induced by protegrin, and it
could only be inhibited by BAPTA, a Ca2+ chelator (Fig. 5B). In ad-
dition, protegrin was the only AMP that maintained high levels of
free radicals for 24 h (Fig. 4C). The results related to cell death
mechanism (Figs. 1–5) suggested that these β-hairpin AMPs did
not produce a speciﬁc type of cell death, but they could activate
several cell death mechanisms simultaneously.
4.2. Morphological differences observed in cell membrane by AMPs at
high concentration
The effects observed with high concentrations of AMPs occur
quickly (less than 20 min), unlike to other cytotoxic agents, and
seem to primarily occur at the cell membrane (Fig. 6 and Fig. S1).
It has been suggested that AMPs induce cell death by opening
pores in cellular membranes, or that they possess a detergent-like
effect resulting in membrane permeabilization [14,16,33–35]. Confo-
cal evaluation of cell membranes showed alterations in membrane
appearance when cells were treated with the EC50 concentration of
the AMPs. However, the morphological integrity of the cell mem-
branes appeared to remain (Fig. 7A). Spatial evaluation of cells
after treatment with gomesin showed a reduction in cell volume
when compared with control cells (Fig. 7B). Conversely, treatment
with 40 μM of AMPs induced a major alteration in cellular structure,
whereas treatment with magainin II, Lin-gomesin and Lin-protegrin
did not alter cell appearance (Figs. 6 and 7C). Different changes in
cell membrane integrity were observed for the different AMPs
used (Fig. 7C).
Several models for the interaction of AMPs with membranes have
been established such as barrel-stave, carpet or toroidal-pore models
[36]. Although these models may be useful for understanding the ac-
tions of AMPs in bacteria or lipid vesicles, their relevance for under-
standing membrane disruption in mammalian cells need to be
clariﬁed. A comparison of cell membrane disruption by different
AMPs also showed differences in membrane alterations. Temporal
images shown here clearly support this hypothesis evidencing differ-
ent kinds of membrane permeabilization, which deserves further in-
vestigation (see Movies in supplementary material).
Indeed morphological and volume evaluation of time-lapse im-
ages allowed to distinguish the diverse cell membrane perme-
abilization at high concentration by each β-hairpin AMP used in
this study (Fig. S3–S10). Large differences in cell membrane per-
meabilization may be observed among structurally similar β-
hairpin AMPs such as gomesin and protegrin, and tachyplesin and
polyphemusin, or even between tachyplesin (or polyphemusin)
and its linear counterpart.
It is believed that the main mode of action of these peptides on cell
death in mammals' cells occurs through non-receptor mediated inter-
actions with the external membrane because D-isoforms of AMPs are
as cytotoxic as the native peptide [1,37,38]. Another theory that has
been proposed to explain the action of these peptides relates to the
cationic nature of most of these peptides. In this regard, electrostatic
interactions between cationic AMPs and anionic cell membrane com-
ponents are assumed to be a main feature in the interaction of AMPs
with cancer cells [4,39–42]. Studies performed with negative and
neutral bilayers have shown that protegrin and gomesin interact
preferentially with negative bilayers compared to neutral bilayers
that contain cholesterol [11,43]. This preference of AMPs for negativemembranes over cholesterol containing membranes, such as mam-
malian cell membranes, explains the range of potency of AMPs
in bacteria (0.1–2 μM), whereas in mammalian cells 10–50-fold
(1–100 μM) higher concentrations of AMPs are necessary to induce
membrane disruption [1,11,44].
4.3. Difference among the effects elicited by β-hairpin AMP
A possible explanation for the different cell death mechanisms
triggered by β-hairpin AMPs at low concentration could be related
to their interactions with extracellular molecules and cell membranes
and their capacity to be endocytosed by the cells, as has been shown
by several other reports [1,4,38,39]. It is possible that different AMPs
may be targeted to different extracellular and intracellular structures
to activate several cell death pathways. Given the negative charge of
mitochondrial membranes and their structural similarity with bacte-
ria membrane, it is possible that mitochondria are the preferential
target for AMP leading to the activation of cell death such as apopto-
sis. Such a hypothesis is supported by studies that have shown that
treatment with AMPs disrupts mitochondrial potential and other mi-
tochondrial functions [28,45,46].
In contrast, the differences of cell membrane disruption at high
concentration could be related to different interactions of AMPs
with several components of cells such as extracellular matrix mole-
cules and lipids, or with structural characteristics such as spatial con-
formation, hydrophobicity, and charge distribution.
Investigations that clarify the mode of action of AMPs are impor-
tant, since they may impact on their potential development as antitu-
mor agents. Although, the preference of AMPs by cancer cells is not
clear, several reports show a highest cytotoxicity potency of AMPs
against tumor cells than normal cells [2,47]. In a recent study, we
only observed some differences of cytotoxicity potency of AMPs
(gomesin, protegrin, tachyplesin and polyphemusin) when compared
to normal mononuclear cells, K562 and HL-60, a human promyelocy-
tic leukemia lineage, but some AMPs were able to affect these line-
ages with concentration that did not induce cell death, but inducing
arrest of cell cycle and immunomodulation (unpublished results).
As demonstrated in this study, even structurally similar AMPs can
promote different effects at low and at high concentration [1,39].
Some reports have also shown similar effect of AMP between normal
and cancer cells, therefore the relationship between AMP structure
and activity is relevant to further explore the ability of these mole-
cules against cancer cells, especially against resistant populations.
5. Conclusions
In this study we described diverse effects promoted by β-hairpin
AMPs with similar tridimensional structures. We clearly distinguish
between two biological effects promoted by β-hairpin AMPs at low
and high concentration. We showed that despite of similar conforma-
tion these β-hairpin AMPs can promote activation of diverse intracel-
lular mechanisms of cell death (at low concentration), and several
forms of membrane disruption (at high concentration). In addition,
by comparing AMPs to their linear analogs, we observed that lineari-
zation is not sufﬁcient to reduce the cytotoxic ability of AMPs. In this
study, controlled intracellular mechanism and direct membrane dis-
ruption were clearly distinguished for the ﬁrst time helping to under-
stand the real action of AMPs in mammalian cells.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbagen.2012.02.015.
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